To amend the Public Health Service Act to enhance the clinical trial registry data bank reporting requirements and enforcement measures.
The bill’s titles are written by its sponsor.
Jun 6, 2013
113th Congress, 2013–2015
Died in a previous Congress
This bill was introduced on June 6, 2013, in a previous session of Congress, but was not enacted.
Representative for New York's 23rd congressional district
Read Text »
Last Updated: Jun 6, 2013
Length: 3 pages
Jun 6, 2013
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Jan 28, 2015
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 617 (114th).
H.R. 2301 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2017). H.R. 2301 — 113th Congress: Clinical Trial Cancer Mission 2020 Act. Retrieved from https://www.govtrack.us/congress/bills/113/hr2301
“H.R. 2301 — 113th Congress: Clinical Trial Cancer Mission 2020 Act.” www.GovTrack.us. 2013. August 23, 2017 <https://www.govtrack.us/congress/bills/113/hr2301>
|title=H.R. 2301 (113th)
|accessdate=August 23, 2017
|author=113th Congress (2013)
|date=June 6, 2013
|quote=Clinical Trial Cancer Mission 2020 Act